A Phase I/IIa study has shown that arfolitixorin along with either irinotecan or oxaliplatin could shrink the size of tumours in colorectal cancer patients...
The post Arfolitixorin linked to tumour shrinkage in colorectal cancer appeared first on European Pharmaceutical Review.
Original Article: Arfolitixorin linked to tumour shrinkage in colorectal cancer